What You Should Know:
Eli Lilly announced an agreement to acquire Versanis, a private clinical-stage biopharmaceutical company focused on the development of new medicines for the treatment of cardiometabolic diseases for $1.925B in cash. Versanis' lead asset is bimagrumab, a monoclonal antibody that binds activin type II A and B receptors to block activin and myostatin signaling. Bimagrumab is currently being assessed in the BELIEVE Phase 2b study alone and in combination with
Read More
Healthcare M&A | M&A News, Analysis, Insights - HIT Consultant
M&A: ResMed Acquires Somnoware to Expand Sleep Management Offerings
What You Should Know:
ResMed, the #1 global producer of CPAP machines and masks to treat sleep apnea acquires Somnoware, a U.S. leader in sleep and respiratory care diagnostics software. Financial details of the acquisition were not disclosed. Somnoware software streamlines the processes of physicians and sleep labs for diagnosing and evaluating a patient’s sleep and respiratory care test results, ordering treatment equipment, setting up appointments, tracking therapy compliance,
Read More
Quest Diagnostics Completes Acquisition of Haystack Oncology
What You Should Know:
Quest Diagnostics announced that it has completed its $450M acquisition of Haystack Oncology.Haystack Oncology has developed a highly sensitive minimal-residual disease (MRD) testing technology, based on circulating tumor DNA (ctDNA), to aid in the early detection of residual or recurring cancer and better inform therapy decisions.Acquired back in April, the acquisition will leverage Quest’s expertise and scale in oncology, genomics and pathology. Quest
Read More
M&A: Apixio and ClaimLogiq Merge to Minimize Reimbursement Inaccuracies
What You Should Know:
Apixio announced it has completed its merger with ClaimLogiq, a healthcare technology business that delivers savings for health plans by reducing claim errors prior to payment. Together, the combined entity will be branded as Apixio.Together, the combination of Apixio and ClaimLogiq’s critical infrastructure, artificial intelligence, and proprietary healthcare data will accelerate the shift toward outcomes-based reimbursement models by reducing costs, minimizing
Read More
M&A: BurstIQ Acquires Olive AI’s Business Intelligence Platform
What You Should Know:
BurstIQ, a provider of data-driven healthcare solutions announced it has acquired Olive AI's business intelligence solution. The acquired solution, now known as LifeGraph Intelligence, further enhances BurstIQ's offerings, revolutionizing how organizations see and use their data. Financial details of the acquisition were not disclosed. The strategic acquisition expands BurstIQ's portfolio of innovative products, reinforcing its commitment to helping healthcare
Read More
Wolters Kluwer Health Acquires AI Drug Diversion Detection Company Invistics
What You Should Know:
Wolters Kluwer Health today announced the acquisition of Invistics Corporation (Invistics), a U.S.-based provider of cloud-based, AI-enabled software for drug diversion detection and controlled substance compliance. Invistics will join the company’s Clinical Surveillance, Compliance & Data Solutions unit, part of Clinical Solutions. Financial details of the acquisition were not disclosed. Invistics’ solution, Flowlytics, uses predictive analytics to detect
Read More
M&A: Cardinal Health’s Outcomes to Merge with Transaction Data Systems
What You Should Know:
Cardinal Health today announced it has signed a definitive agreement to contribute its Outcomes™ business to Orlando-based Transaction Data Systems (TDS) in exchange for a minority stake in the combined entity.Under the terms of the merger agreement, Cardinal Health’s pharmaceutical segment CEO, Debbie Weitzman, will be appointed to the TDS board of directors.TDS’s existing portfolio of clinical pharmacy solutions includes the Rx30 and Computer-Rx pharmacy
Read More
M&A: Florence Acquires Virtual Care Solution Zipnosis
What You Should Know:
Florence, an innovator in healthcare enablement software, announced today its acquisition of Zipnosis, an asynchronous-first virtual care solution that creates efficiency for clinicians while making quality care more accessible and affordable for patients. Through this acquisition, Florence will broaden its product offerings with synchronous and asynchronous virtual care and further their mission to create a consumer-centric interface that
Read More
5 Executives Weigh in on VBC Impact on Kaiser/Geisinger Deal
We recently asked five digital health executives to share their insights on the recent Kaiser's recent acquisition of Geisinger Health and it's impact to accelerate value-based care.
Andy Flanagan, CEO of Iris Telehealth
This acquisition presents a significant upside for the industry's move to improve access to quality, affordable care. Kaiser and Geisinger are two of the premier organizations in our country driving towards value-based care at scale for their communities. The creation
Read More
M&A: ArisGlobal Acquires SPORIFY to Expand Regulatory Solutions
What You Should Know:
ArisGlobal, a provider of life sciences software acquires SPORIFY, the trusted substances, products, organizations and referentials (SPOR) data harmonization technology solution for five of the world’s top 20 largest pharmaceutical companies. Financial details of the acquisition were not disclosed.With its second acquisition in the last 90 days, ArisGlobal is prioritizing the development of an open architecture that enables an interconnected life sciences ecosystem.The
Read More
